Abstract:Extracorporeal shock wave therapy (ESWT) is known as an effective method for inflammatory diseases treatment of various localization. It is actual and perspective treatment methos for chronic calculous prostatitis (CCP). The objective: to evaluate the dynamics and interrelationships of clinical symptoms, twinkling artifact, the levels of leukocytes and cytokines in the ejaculate during the use of ESWT for the treatment of patients with CCP. Materials and methods. The study included 37 patients with aged 18–45 years with CCP after ESWT in the projection of the prostate gland (PG). The participants of the study were assessed for prostatitis symptoms according to the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI), depression symptoms - Patient Health Questionnaire-9 (PHQ-9); anxiety symptoms – Generalized Anxiety Disorder-7 (GAD-7), sexual dysfunction symptoms – International Index of Erectile Function (IIEF). Patients had ultrasonographic examination of the pelvic organs with the determination of a twinkling artifact. The levels of IL-1β and IL-10 in ejaculate before and after treatment were determined using enzyme immunoassay. For the analysis of the treatment results, the patients with a significant reduction in the activity of symptoms of PG (by 6 or more points on the NIH-CPSI scale) were included in subgroup A. The patients with insufficient efficacy were involved in subgroup B. Results. A clinically significant reduction in the severity of prostatitis symptoms (by 6 or more NIH-CPSI points) as a result of treatment was observed in 27 (72.9%) patients. The total prostatitis symptom score (NIH-CPSI) (p<0.05), as well as domains of pain, dysuria and impact on patients’ quality of life, intensity of symptoms of depression, anxiety and erectile dysfunction changed significantly. Changes in the IL-1β and IL-10 concentrations in the ejaculate did not depend on the clinical improvement of the patients’ condition. Before treatment, the concentration of IL-1β in the ejaculate was positive correlated with the index of depression symptoms (r=0.381, р=0.020) and negative correlated with the indicators of erection, orgasm and sexual desire (r=–0.326, р=0.049; r=-0.329, р =0.046; r=–0.389, p=0.017, respectively). After treatment, the concentration of IL-1β in the ejaculate was positive correlated with the general assessment of prostatitis symptoms, quality of life and anxiety symptoms (r=0.339, р=0.040; r=0.358, р=0.029; r=0.334, р=0.044, respectively), and also negative correlated with indicators of orgasm and sexual desire (r=–0.421, p=0.009; r=–0.455, p=0.005, respectively). A decrease in the frequency of twinkling artifact in the PG projection was found. At the same time, no significant changes in the presence of echo-positive inclusions were detected. Before treatment, a significant correlation of the presence of twinkling artifact was determined with the total score of prostatitis symptoms (r=0.448, p=0.005), domains of pain (r=0.404, p=0.013) and quality of life (r=0.331, p=0.045), orgasm (r =–0.469, p=0.003) and sexual desire (r=–0.350, p=0.034). No correlation was found with other investigated indicators. Conclusions. The results of the study demonstrated that ESWT provides a significant reduction in symptoms of prostatitis, anxiety, depression and erectile dysfunction through a dosed anti inflammatory and anticalcification effect on the PG. The use of Doppler twinkling artifact can be useful for characterizing and monitoring the treatment of PG calcifications.

Safety and Efficacy of Extracorporeal Shockwave Therapy on Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

Effects of extracorporeal shock wave on the treatment of Chronic prostatitis/Chronic pelvic pain syndrome in males

Efficacy of Low-Intensity Extracorporeal Shock Wave Therapy for the Treatment of Chronic Pelvic Pain Syndrome IIIb: A Prospective-Randomized, Double-Blind, Placebo-Controlled Study

Extracorporeal Shockwave Therapy (ESWT) Alleviates Pain, Enhances Erectile Function and Improves Quality of Life in Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Short and long-term effectiveness of external shock wave therapy for chronic pelvic pain syndrome in men

Efficacy and safety of treating chronic nonspecific low back pain with radial extracorporeal shock wave therapy (rESWT), rESWT combined with celecoxib and eperisone (C + E) or C + E alone: a prospective, randomized trial

Extracorporeal shockwave therapy in treatment of chronic prostatitis/chronic pelvic pain syndrome: Systematic review and meta‐analyses

Efficacy of Radial Extracorporeal Shock Wave Therapy for Chronic Pelvic Pain Syndrome: A Nonrandomized Controlled Trial

Efficacy and Safety of Extracorporeal Shock Wave Therapy in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Acquired Premature Ejaculation Patients

Extracorporeal Shockwave Therapy Alleviates Inflammatory Pain by Down-Regulating NLRP3 Inflammasome in Experimental Chronic Prostatitis and Chronic Pelvic Pain Syndrome.

The Efficacy and Safety of Low-Intensity Extracorporeal Shock Wave Treatment Combined with or Without Medications in Chronic Prostatitis/chronic Pelvic Pain Syndrome: a Systematic Review and Meta-Analysis

Extracorporeal Shock Wave Therapy for Chronic Pelvic Pain Syndrome: an Update

Extracorporeal Shock Wave Therapy in the Treatment of Chronic Calculous Prostatitis

Efficacy of Low-Intensity Extracorporeal Shock Wave Therapy on Men With Chronic Pelvic Pain Syndrome Refractory to 3-As Therapy

Efficacy and Safety Evaluation of Low-Intensity Extracorporeal Shock Wave Therapy on Prostatitis-Like Symptoms: an Open-Label, Single-Arm Trial

Correction of chronic prostatitis by extracorporeal shock wave therapy

Outcomes and clinical predictors of extracorporeal shock wave therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome: a prospective randomized double-blind placebo-controlled clinical trial

The role of gut microbiota involved in prostate microenvironment and symptoms improvement in chronic prostatitis/chronic pelvic pain syndrome patients treated with low-intensity extracorporeal shock wave

Extracorporeal Shockwave Therapy for Greater Trochanteric Pain Syndrome: A Systematic Review with Meta-Analysis of Randomized Clinical Trials

Extracorporeal shock wave therapy decreases the number of total and degranulated mast cells and alleviates pelvic pain in a rat model of prostatitis

Comparing the effectiveness of extracorporeal shockwave therapy and myofascial release therapy in chronic pelvic pain syndrome: study protocol for a randomized controlled trial